During the past decade, Hospital Infantil La Paz conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Infantil La Paz" #1 sponsor was "Gilead Sciences" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Mirum Pharmaceuticals, Inc." with 2 trials sponsored, "BioMarin Pharmaceutical" with 1 trials sponsored and "Diamyd Therapeutics AB" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Infantil La Paz" #1 collaborator was "Aristotle University Of Thessaloniki" with 1 trials as a collaborator, "Bambino Gesù Hospital and Research Institute" with 1 trials as a collaborator, "Cardiff University" with 1 trials as a collaborator, "Consorzio per Valutazioni Biologiche e Farmacologiche" with 1 trials as a collaborator and "European Commission" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Infantil La Paz" are "Cystic Fibrosis" (2 trials), "Empyema" (2 trials), "Acute Heart Failure" (1 trials), "Alagille Syndrome" (1 trials) and "Analgesia" (1 trials). Many other conditions were trialed in "Hospital Infantil La Paz" in a lesser frequency.

Most popular intervention types in "Hospital Infantil La Paz" are "Drug" (12 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "AZLI" (1 trials), "Activated and expanded natural killer cells (NKAEs)" (1 trials), "Aztreonam for Inhalation Solution (AZLI)" (1 trials) and "Conventional intensified inotropic treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Infantil La Paz" are 14 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Infantil La Paz". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Hospital Infantil La Paz, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Infantil La Paz, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Hospital Infantil La Paz has several departments that took part in Clinical trials: "Hospital Universitario la Paz; Servicio de Hematologia" - 21 trials, "Hospital Universitario La Paz; Servicio de Oncologia" - 54 trials, "Hospital de La Paz; Unidad de Reumatologia Pediatrica" - 4 trials, "Hospital Universitario La Paz; Unidad Metabolico-Vascular" - 3 trials, "Servicio de Cirugía Ortopédica y Traumatología "A", Hospital La Paz" - 3 trials